Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD)

NCT03325894 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

141

Enrollment

INDUSTRY

Sponsor class

Stopped The study was stopped due to efficacy reasons.

Conditions

Attention Deficit Hyperactivity Disorder (ADHD)

Interventions

DRUG: SHP465

Sponsor

Shire